Edition:
United States

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

2.77USD
4:00pm EDT
Change (% chg)

$-0.04 (-1.42%)
Prev Close
$2.81
Open
$2.77
Day's High
$2.85
Day's Low
$2.77
Volume
2,430
Avg. Vol
8,248
52-wk High
$5.46
52-wk Low
$0.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.00 -0.377
FY 2017 Sep '17 0.00 -0.448
Jun '17 0.00 -0.489
Mar '17 0.00 -0.549
Dec 0.00 -0.444
FY 2016 Sep '16 0.00 -0.530
Jun '16 0.00 -0.746
Mar '16 0.00 -0.350
Dec 0.00 -0.532
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Sep-18 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Sep-18 1 -1.25 -1.25 -1.25 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.61 33.50
P/E High - Last 5 Yrs. -- 40.54 46.07
P/E Low - Last 5 Yrs. -- 24.12 24.95
Beta -- 0.81 0.80
Price to Sales (TTM) -- 4.64 7.25
Price to Book (MRQ) 1.08 4.03 5.09
Price to Tangible Book (MRQ) 5.76 4.85 6.62
Price to Cash Flow (TTM) -- 22.54 25.50
% Owned Institutions 6.44 1.17 2.24

Dividends

  Company industry sector
Dividend Yield -- 1.63 1.53
Dividend Yield - 5 Year Avg -- 0.73 0.75
Dividend 5 Year Growth Rate -- 2.71 3.92
Payout Ratio(TTM) -- 20.34 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.87 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 9.82 11.19
Sales - 5 Yr. Growth Rate -- 7.66 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 14.98 19.83 22.73
EPS (TTM) vs TTM 1 Yr. Ago 9.98 -- --
EPS - 5 Yr. Growth Rate -- 8.96 10.28
Capital Spending - 5 Yr. Growth Rate -- 9.68 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.53 2.53
Current Ratio (MRQ) 2.86 3.61 3.61
LT Debt to Equity (MRQ) 0.00 8.75 11.39
Total Debt to Equity (MRQ) 0.67 11.04 14.02
Interest Coverage (TTM) -34.39 46.23 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.69 54.05
Gross Margin - 5 Yr. Avg. -- 52.13 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.41 15.90
Operating Margin (TTM) -- 12.81 4.09
Operating Margin - 5 Yr. Avg. -- 14.18 11.23
Pre-Tax Margin (TTM) -- 13.05 4.81
Pre-Tax Margin - 5 Yr. Avg. -- 14.53 11.54
Net Profit Margin (TTM) -- 9.46 1.42
Net Profit Margin - 5 Yr. Avg. -- 10.86 7.87
Effective Tax Rate (TTM) -- 22.48 30.96
Effective Tax Rate - 5 Yr. Avg. -- 23.66 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 918,428,665 813,295,447
Net Income/Employee (TTM) -- 107,983,553 95,590,786
Receivable Turnover (TTM) -- 5.60 5.56
Inventory Turnover (TTM) -- 2.55 3.44
Asset Turnover (TTM) 0.00 0.91 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.86 10.94 10.51
Return on Assets - 5 Yr. Avg. -- 12.13 11.54
Return on Investment (TTM) -55.85 13.57 13.17
Return on Investment - 5 Yr. Avg. -- 15.68 14.94
Return on Equity (TTM) -55.85 15.25 14.98
Return on Equity - 5 Yr. Avg. -- 16.85 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 17.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Citius Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.44%
# of Holders: 8
Total Shares Held: 686,854
3 Mo. Net Change: 449,118
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.